← Back
$MDGL All transactions

MADRIGAL PHARMACEUTICALS, INC.

▼ SELL 10b5-1 Plan

$ Value

$252K

Shares

700

Price

$360

Filed

Aug 13

Insider

Name

Taub Rebecca

Title

CIK

0001423898

Roles

Director

Transaction Details

Transaction Date

2025-08-12

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

461,044

Footnotes

These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2025. | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $350.00 to $350.92, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and the footnotes below. | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $351.00 to $351.24, inclusive. | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $350.10 to $351.08, inclusive. | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $351.16 to $352.12, inclusive. | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $352.17 to $353.01, inclusive. | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $353.43 to $354.42, inclusive. | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $354.44 to $355.43, inclusive. | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $355.44 to $356.43, inclusive. | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $356.44 to $357.41, inclusive. | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $357.44 to $358.43, inclusive. | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $358.44 to $359.43, inclusive. | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $359.51 to $359.78, inclusive. | The Reporting Person and her spouse are each managing members of SQN, LLC. The Reporting Person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, if any, and the inclusion of these shares in this report shall not be deemed an admission of the beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. | The shares underlying this stock option are fully vested and exercisable.

Filing Info

Accession No.

0001423898-25-000005

Form Type

4

Issuer CIK

0001157601

Taub Rebecca's History

Date Ticker Type Value
2025-08-12 MDGL M $409K
2025-08-12 MDGL $1.3M
2025-08-12 MDGL $1.0M
2025-08-12 MDGL $414K
2025-08-12 MDGL $1.6M
2025-08-12 MDGL $2.3M
2025-08-12 MDGL $2.0M
2025-08-12 MDGL $1.7M
2025-08-12 MDGL $2.4M
2025-08-12 MDGL $2.3M

Other Insiders at MDGL (90d)

No other insider activity at this issuer in the last 90 days.